Full Text View
Tabular View
No Study Results Posted
Related Studies
North American Study of Epistaxis in HHT (NOSE)
This study is currently recruiting participants.
Verified April 2013 by Georgia Regents University
Study NCT01408030   Information provided by Georgia Regents University

First Received on August 1, 2011.   Last Updated on April 17, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Epistaxis
Additional conditions recognized in this trial
Telangiectasia, Hereditary Hemorrhagic
Telangiectasis
More general conditions related to this trial
Cardiovascular Abnormalities
Cardiovascular Diseases
Congenital Abnormalities
Hematologic Diseases
Hemorrhage
Hemorrhagic Disorders
Hemostatic Disorders
Nose Diseases
Otorhinolaryngologic Diseases
Pathologic Processes
Respiratory Tract Diseases
Vascular Diseases
Vascular Malformations
Interventions listed in this trial
Sterile saline
Bevacizumab
Estriol
Tranexamic Acid
Additional drug interventions recognized in this trial
Estrogens
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antifibrinolytic Agents
Antineoplastic Agents
Coagulants
Fibrin Modulating Agents
Growth Inhibitors
Growth Substances
Hematologic Agents
Hemostatics
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
James Gossage
Hereditary Hemorrhagic Telangiectasia Foundation International


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services